Wendy future of retail top

BD

SARS-CoV-2 assay for BD Veritor Plus System to be available in Europe by end of October

SARS-CoV-2 assay for BD Veritor Plus System to be available in Europe by end of October

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced on Wednesday that its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor Plus System has been CE marked to the IVD Directive (98/79/EC). The new test delivers results in 15 minutes on an easy-to-use, portable instrument, which is a critical improvement in turnaround

BD and BD Foundation commit $7.8 million to helping community health centers expand innovative care

BD and BD Foundation commit $7.8 million to helping community health centers expand innovative care

FRANKLIN LAKES, N.J. — BD and its charitable affiliate BD Foundation have committed $7.8 million in monetary grants and product donations over the next three years to support the continued expansion of the BD Helping Build Healthy Communities initiative.  This is a unique public-private partnership launched in 2013 and implemented jointly by Direct Relief and the National Association

BD launches portable rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes

BD launches portable rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The launch of this new assay that delivers results in 15 minutes on an

BD, BioMedomics launch of rapid serology test to detect exposure to COVID-19

BD, BioMedomics launch of rapid serology test to detect exposure to COVID-19

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson) and BioMedomics announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19 in as little as 15 minutes. The new test, developed and manufactured by BioMedomics, will be available through BD and distributed exclusively by Henry Schein, Inc.

BD issues statement on COVD-19

BD issues statement on COVD-19

BD issued the following statement on how the company is working with companies and agencies during the COVID-19 outbreak: FRANKLIN LAKES, N.J. — BD is closely monitoring the COVID-19 (coronavirus) situation across the world and guidance from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and health officials in

BD launches 6mm Ultra-Fine pen needle

BD launches 6mm Ultra-Fine pen needle

FRANKLIN LAKES, N.J.— Becton Dickinson (BD) has rolled out its new 6mm x 32G Ultra-Fine micro pen needle. With the launch, BD is providing health care providers with an additional needle length option for people with diabetes who inject insulin. The introduction of the new pen needle rounds out the BD Ultra-Fine pen needle portfolio,

PP_1170x120_10-25-21